Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017

Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017 Category: Healthcare

www.researchonglobalmarkets.com

Insert Image Height - 3.60 Width – 4.98

http://bit.ly/ischemic-stroke




http://www.researchonindia.com/

http://www.researchonglobalmarkets.com/

https://www.facebook.com/pages/Research-on-Global-Markets/536186973101152

http://www.linkedin.com/groups?gid=5131467&mostPopular=&trk=tyah

https://twitter.com/researchonglobe


• The main driver of the expansion of the AIS market will be the launch

of Lundbecks next-generation thrombolytic agent desmoteplase,

which has an extended therapeutic time window of up to 9 hours

post-stroke onset

• Other key market drivers include the implementation of

telemedicine, rapidly growing and ageing population, resulting in a

rise in stroke incidence

• Clinical trials attrition in the late-stage pipeline continues to hamper

R&D efforts to bring novel therapies onto market, meaning AIS

patients are still restricted to few effective treatment options

Report Insights

Report: Opportunity Analyzer Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017








• Stringent eligibility criteria for thrombolysis treatment, as well as a

narrow therapeutic time window, means the majority of AIS patients

are currently not treated with Activase/Actilyse

• While current thrombolytics are mostly held back by safety concerns

when used beyond their intended therapeutic time window, there is

ample opportunity for an effective and safe therapy that can be

given after nine hours post-stroke onset

Report Insights (Continued)









• Overview of AIS, including epidemiology, etiology, pathophysiology,

symptoms, diagnosis and treatment guidelines

• Annualized AIS therapeutics market revenue, annual cost of therapy

and treatment usage pattern data from 2012 and forecast for five

years to 2017

• Key topics covered include market characterization, unmet needs,

R&D and clinical trials assessment, late stage clinical trial analysis and

implications for the AIS therapeutics market

• Pipeline analysis: Focus on the principal late-stage pipeline drug

discussing emerging trends as well as overview of earlier phase drugs

Report Coverage









• Analysis of the current and future market competition in the global

AIS therapeutics market

• Insightful review of the key industry drivers, restraints and challenges

• Each trend is independently researched to provide qualitative

analysis of its implications

Report Coverage (Continued)









• Develop and design in-licensing and out-licensing strategies through

a review of pipeline products and technologies, and by identifying

the companies with the most robust pipeline

• Develop business strategies by understanding the trends shaping and

driving the global AIS therapeutics market

• Drive revenues by understanding the key trends, innovative products

and technologies, market segments, in addition to companies likely

to impact the global AIS therapeutics market in future

• Formulate effective sales and marketing strategies by understanding

the competitive landscape and performance of various competitors

Report Benefits









• Identify emerging players with potentially strong product portfolios

and create effective counter-strategies to gain a competitive

advantage

• Track drug sales in the global AIS therapeutics market from 2012-

2017

• Organize sales and marketing efforts by identifying the market

categories and segments that present maximum opportunities for

consolidations, investments and strategic partnerships

Report Benefits (Continued)









Table of Contents

• Introduction

• Disease Overview

• Epidemiology

• Current Treatment Options

• Unmet Needs Assessment and Opportunity Analysis

• R&D Strategies

• Pipeline Assessment

• Pipeline Valuation Analysis

• Appendix









• Publish date: Dec 30, 2013

• Number of slides: 162

• Geographic coverage: Global

• Available format: PDF, CD, Hardcopy

• Price for Single User License: USD 5,995

• Price for Site License: USD 11,990

• Price for Global User License: USD 17,985

• Delivery Time: Within 1 business day

• Payment Modes: Credit/Debit Card, RTGS/Wire Transfer, Google

Wallet, PayPal

Report Details









Interested in this report?

About Us Research on Global Markets is a leading source for market research on various sectors globally offering premium research content from worldwide publishers of market research reports

For further information, get in touch with us:

E-mail: [email protected] Call: US: +1 866 325 7446 UK: +44 203 514 2363 Others: +91 22 4098 7600

Industry Segments

Automotive & Transport Consumer goods Agriculture

Food and Beverage Energy and Utilities Public Sector

Manufacturing & Construction Healthcare Media & Entertainment

IT, Telecom & Electronics Services Others

To view more details regarding this premium market research report, Please click here






Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017

Documents

Transcript of Acute Ischemic Stroke - Opportunity Analysis and Forecasts to 2017